| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $40K | — | — |
| Cost of Revenue | $49K | — | — |
| Gross Profit | -$8K | — | — |
| R&D Expense | $25K | — | — |
| SG&A Expense | $151K | — | +53.7% |
| Operating Income | -$151K | — | -50.8% |
| Pre-tax Income | -$175K | — | +11.1% |
| Income Tax | $3K | — | — |
| Net Income | -$175K | -43.9% | +11.1% |
| EPS (Basic) | -$0.01 | — | +50.0% |
| EPS (Diluted) | -$0.01 | — | +50.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $13K | — | — |
| Inventory | $62K | — | — |
| Current Assets | $1.4M | — | — |
| Total Assets | $2.1M | — | — |
| Current Liabilities | $8.8M | — | — |
| Stockholders' Equity | -$6.7M | -5.8% | -74.8% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $4K | — | +143.5% |
| Investing Cash Flow | -$4K | — | +97.9% |
| Financing Cash Flow | -$107 | — | -100.1% |